Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy
To access this article, please choose from the options below
PII: S0169-5002(10)00064-4
doi:10.1016/j.lungcan.2010.01.021
© 2010 Published by Elsevier Inc.
